Short bevacizumab infusion as an effective and safe treatment for colorectal cancer

Bevacizumab is a humanized monoclonal antibody that contains <10% murine protein. To prevent infusion-related hypersensitivity reactions (HSRs), the initial bevacizumab infusion is delivered for 90 min, the second for 60 min and subsequent doses for 30 min. Several previous studies have shown tha...

Descripción completa

Detalles Bibliográficos
Autores principales: Taira, Koichi, Okazaki, Shunsuke, Akiyoshi, Kohei, Machida, Hirohisa, Ikeya, Tetsuro, Kimura, Akie, Nakata, Akinobu, Nadatani, Yuji, Ohminami, Masaki, Fukunaga, Shusei, Otani, Koji, Hosomi, Shuhei, Tanaka, Fumio, Kamata, Noriko, Nagami, Yasuaki, Fujiwara, Yasuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353868/
https://www.ncbi.nlm.nih.gov/pubmed/35949896
http://dx.doi.org/10.3892/mco.2022.2572

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353868/
https://www.ncbi.nlm.nih.gov/pubmed/35949896
http://dx.doi.org/10.3892/mco.2022.2572

Ejemplares similares